GARDEN-TIMI 74

GARDEN-TIMI 74 is a phase 2 trial testing the effect of ponsegromab, a novel monoclonal antibody directed against growth differentiation factor (GDF)-15, on health status and physical activity in patients with heart failure and elevated circulating GDF-15 concentrations.

GARDEN Trial Schema TIMI Website

GARDEN on ClinicalTrials.gov

CONTACT US about GARDEN

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close